Skip to content
Live funding
Sesame Summit 2027
Sesamers

Treat raises €3M pre-seed for AI-assisted intake in private healthcare

Helsinki's Treat has raised a €3M pre-seed from byFounders and Illusian. Its software briefs a doctor on each patient before the visit, and employers pay for it.

Helsinki Cathedral rising above the waterfront buildings of Helsinki at autumn sunset. Photo: Tapio Haaja / Unsplash

Also see more funding coverage: /funding/

Round at a glance
€3MPre-seed Announced 16 November 2026
CompanyTreat · profile
StagePre-seed
Participants Illusian

Treat, a Helsinki healthtech founded in 2026, has raised a €3M pre-seed round from byFounders and Illusian to connect patients with doctors who have already read their history before the consultation starts.

Below, I lay out who backed it, what the product does, how big the market is and what to watch next.

Get the Weekly brief

The week’s rounds, last calls and events, every Monday.

byFounders and Illusian write the first big check

Tech.eu and Tech Funding News reported the round on 17 November 2026. Tech.eu names byFounders and Illusian as the lead investors. Illusian is the investment firm of Supercell founder Ilkka Paananen, and byFounders and Illusian are both already in our investor directory.

According to Tech Funding News, the round closed a week after the first conversation with byFounders, which was the preferred investor. The €3M will mainly go toward product development and expansion, and CEO Sami Marttinen expects Treat to be active in more than five countries by the end of the year.

Sara Rywe, general partner at byFounders, framed the thesis to Tech.eu: “Private healthcare across the globe is bogged down by fragmented systems and mismatched incentives.”

Nine repeat visits and one page of A4

Treat was founded in 2026 and now has nine team members. Marttinen, the former CEO of Swappie, leads it with Antti Mauno, a medical doctor, and Onni Wahlberg, who runs fintech engineering. The idea came from home. “Three years ago, my wife had to go through nine repeat doctor visits in private care before receiving a diagnosis,” Marttinen told Tech.eu. He summarized her file on a single A4 page, and the eighth doctor used it to refer her to a specialist, as reported by Tech Funding News.

The product starts with the patient describing symptoms in their own words. The software asks follow-up questions, checks insurance and employer coverage, and hands the doctor a brief to review before the consultation. Most cases are resolved in one digital consultation and the rest are referred to the right specialist. Employers offer Treat to staff alongside private health insurance and occupational healthcare. Treat says patient data is not sent to public language models and that only licensed physicians access medical histories.

The company reports more than 20 pilot employers, mostly global businesses, including one with 1,300 employees, plus its first few thousand users. By the company’s own claim, 83% of cases are resolved on the first visit. Treat also says it earns zero revenue from lab tests, clinic visits or referrals.

A European telehealth market compounding at 16%

IMARC Group sizes the European telehealth market at USD 6.62 billion in 2025 and forecasts USD 25.98 billion by 2034, a 16.4% CAGR over 2026-2034 (page updated 29 October 2026). Treat sells to employers and does not sell to health systems, so its addressable market is the slice of that spending that a company chooses to put in front of its staff. No source we found sizes that slice for Finland or for Europe.

Two recent rounds in our fundraising data give the €3M some scale. Usawa Care closed a €2.7M seed on 7 October 2026, and Yazen’s $50M Series B followed a day later. A pre-seed with a nine-person team sits at the small end of that range, which fits a company still running pilots.

Who gets paid when the visit count stops mattering

The hard fact in private care is that many providers earn more when a patient comes back. Marttinen told Tech Funding News the problem is an economic model that rewards repeat visits over efficient resolution. The silver lining is that an employer paying the bill has the opposite incentive, and Treat sells to that buyer. It says it has no direct competitor and names occupational healthcare providers and insurers as indirect ones.

That leaves two numbers to watch. The 83% first-visit figure comes from the company and has yet to meet larger volumes. And more than five countries by year-end means more than five sets of insurers, employers and licensing rules, all in about six weeks.

Imagine if a Helsinki employee and a Madrid employee opened the same intake and reached a doctor with the same one-page summary. Europe has the employers, the insurers and the founders who lived the problem. Watch the country list, and let’s see how far one A4 page travels!

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.